Swine flu virus now resistant to current medicine Tamiflu

Image
Press Trust of India Melbourne
Last Updated : Mar 18 2013 | 5:25 PM IST
Swine flu virus may be now resistant to key medicine Tamiflu, raising fears a new outbreak may be difficult to fight, Australian research has warned.
While just 2 per cent of swine flu (H1N1) strains around the world are resistant to Tamiflu, the Australian research found mutations in all strains of the swine flu that suggest they might be prone to develop resistance.
Researchers found that one in five cases of swine flu in one area of Australia in 2011 were resistant to the antiviral medicine.
Dr Aeron Hurt from the World Health Organisation collaborating centre for flu research in Melbourne, said the bug appears more prone than other types of flu to developing drug resistance, The Australian reported.
Tamiflu resistance develops when an individual under treatment receives the drug to control their symptoms. In most flu viruses, the changes that make the virus resistant to treatment also make it less likely to spread to others.
With swine flu, this has not happened and the virus remains fit enough to spread to others, Hurt said.
Research on patients in Newcastle, New South Wales in 2011 found just one person in the area had used Tamiflu but the resistant form of the virus spread to 20 per cent of all those who developed swine flu in that region, News Limited Network reported.
"Widespread transmission of a fit resistant strain is of significant public health concern," Hurt will tell a conference in Canberra tomorrow.
The only way to combat the growth of drug resistant strain of the virus is to save medicines for the most needy cases, he said.
Swine flu has not yet developed resistance to Relenza, an inhaled form of anti-viral treatment.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 18 2013 | 5:25 PM IST

Next Story